Skip to content
naulon
Not checkedNot checked for notices yet.

Acquired resistome and plasmid sequencing of mcr-1 carrying multi-drug resistant Enterobacterales from poultry and their potential transmissibility to humans

M. El-Azzi, A. Sleiman, A. Abou Fayad and 6 more

International Journal of Infectious Diseases · 2022

doi:10.1016/j.ijid.2021.12.007 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Purpose: To investigate the acquired resistome in 18 colistin resistant Escherichia coli isolated from different poultry farms in Lebanon, analyze Inc plasmids associated with mcr, and assess potential transmission to humans. Methods & Materials: A total of 18 E. coli were recovered from poultry feces collected from poultry farms in Lebanon. BMD assay was performed to determine the antimicrobial resistance profiles. Whole-genome sequencing highlighted genetic resistance determinants. Transformation confirmed transmissibility of mcr. Results: BMD results showed that all the 18 isolates were colistin resistant. Transformation confirmed that the plasmids carrying mcr-1 were transmissible. Sequencing showed that ST1140 was the most prevalent. The most frequent resistance determinants were tetA and floR. A total of 15 different plasmid replicon types were identified. The mcr-1 was predominantly located on IncX4 plasmids. Additionally, two isolates harbored the IncI2-type self-conjugative and IncI2-type mcr-1-harboring plasmids respectively. Conclusion: The findings show that mcr was the most prevalent resistance determinant in multi-drug resistant E. coli isolated poultry farms in Lebanon. The occurrence of mcr on mobile plasmids highlights a risk of transmission to humans.

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.